Please use this identifier to cite or link to this item:
Title: Pharmaceutical development of novel microalgal compounds for Mdr Mycobacterium tuberculosis
Authors: Prakash, S
Bhimba, B Valentin
Keywords: Marine microalgae;Microalgal compounds;Tuberculosis;Mdr TB;Mycobacterium tuberculosis;Isochrysis galbana
Issue Date: Aug-2005
Publisher: CSIR
IPC Code: Int. cl.7A61K 35/80, A61P 31/06
Abstract: The role of marine algae in the discovery of drugs that could reach the pharmaceutical market has increased notably in recent years, due to a substantial improvement in biological screening methods. Multi Drug Resistant (MDR) TB is the major hurdle in the TB control programmes. The selected resistant strains of Mycobacterium tuberculosis were screened for the bioactive compounds extracted from marine microalgae. It is noted that Isochrysis galbana has rich bioactive compounds than the other algal species.
Page(s): 264-269
ISSN: 0975-1092 (Online); 0972-592X (Print)
Appears in Collections:NPR Vol.4(4) [July-August 2005]

Files in This Item:
File Description SizeFormat 
NPR 4(4) 264-269.pdf413.12 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.